The 2015 update of the IDF (International Diabetes Federation) Atlas estimates around 69.2 million people in India to be affected by diabetes [1]. As per the United Kingdom Prospective Diabetes Study, 50% of pancreatic beta cells are already lost at the time of diagnosis, with a subsequent decline of 3-5% per year [2]. Hence, most people with type 2 diabetes (T2DM) ultimately require insulin therapy because of the progressive nature of their disease. The difficulty encountered in clinical practice relates to the acceptance of switching over to insulin when oral hypoglycemic agents have failed. Although factors like inaccessibility (lack of personal resources) and inconvenience related to injection and timing of meals play an important role, ‘psychological resistance’ due to executive and emotional dysfunction remains an important yet ignored factor [3]. Yoga is a mind/body practice based on traditional Indian philosophy, often incorporating four major components: physical postures, breathing exercises, meditation and relaxation. Studies comparing yoga to metabolically matched walking have shown a greater improvement in mood, greater decrease in anxiety and increase in levels of thalamic gamma amino butyric acid (on brain magnetic resonance spectroscopy) in yoga asana practitioners [4]. In a systematic review on 25 randomized controlled trials on 2170 participants, yoga was found to improve glycemic control, lipid levels, oxidative stress, blood pressure and pulmonary and autonomic function. In addition, there was a reduced need for medication and improved mood and sleep [5]. Hence, it would be worth studying the effect of yoga (over and above the use of 2/3 oral hypoglycemic agents) in improving glycemic and metabolic control, and see if a systematic yoga protocol can delay insulin initiation in these patients.